Interpreting Rituximab Response in Seronegative Membranous Nephropathy [Response to Letter]
Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-2
DOI: 10.2147/dddt.s631149 ↗Kurz gefasst
Kommentar in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Yang Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Nephrology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
- Department of Nephrology, Yingtan 184 Hospital, Yingtan, People's Republic of China.
Zitieren
APA
Yang, Y., Xie, X., & Xu, G. (2026). Interpreting Rituximab Response in Seronegative Membranous Nephropathy [Response to Letter]. Drug Design, Development and Therapy, Volume 20, 1-2. https://doi.org/10.2147/dddt.s631149
Vancouver
Yang Y, Xie X, Xu G. Interpreting Rituximab Response in Seronegative Membranous Nephropathy [Response to Letter]. Drug Design, Development and Therapy. 2026;Volume 20:1-2. doi:10.2147/dddt.s631149
BibTeX
@article{Yang2026,
author = {Yang, Yang and Xie, Xiaojie and Xu, Gaosi},
title = {Interpreting Rituximab Response in Seronegative Membranous Nephropathy [Response to Letter]},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--2},
doi = {10.2147/dddt.s631149}
}
EUVIMED